1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 18
3.2 Scope of the Study 18
3.3 Research Objective 18
3.4 Assumptions & Limitations 18
3.4.1 Assumptions 18
3.4.2 Limitations 18
3.5 Market Structure 19
4 Research Methodology
4.1 Research Process 21
4.2 Primary Research 22
4.3 Secondary Research 23
4.4 Market Size Estimation 24
4.5 Forecast Model 24
5 Market Dynamics
5.1 Introduction 26
5.2 Drivers 27
5.2.1 Increasing Number of Pet Owners 27
5.2.2 Growing Livestock Population and Disease Outbreaks 27
5.2.3 Advances in Technology underlying Veterinary Vaccines 27
5.2.4 Various Initiatives by Several Government Agencies, Animal Associations, and Prominent Market Players 28
5.3 Restraint 28
5.3.1 High Storage Cost associated with Veterinary Vaccines 28
5.4 Opportunity 28
5.4.1 Rising Investments to Improve Animal Health 28
6 Market Factor Analysis
6.1 Porter’s Five Forces Model 30
6.1.1 Bargaining Power of Suppliers 30
6.1.2 Bargaining Power of Buyers 31
6.1.3 Threat of New Entrants 31
6.1.4 Threat of Substitutes 31
6.1.5 Rivalry 31
6.2 Supply Chain Analysis 31
6.2.1 R&D and Development 32
6.2.2 Manufacturing 32
6.2.3 Distribution & Sales 32
6.2.4 Post-Sales Monitoring 32
7 Veterinary/Animal Vaccines Market, by Type
7.1 Introduction 35
7.1.1 Livestock Vaccines 37
7.1.2 Porcine Vaccines 38
7.1.3 Companion Animal Vaccines 38
7.1.4 Poultry Vaccines 39
7.1.5 Aquaculture Vaccines 39
8 Veterinary/Animal Vaccines Market, by Technology
8.1 Introduction 41
8.1.1 Live Attenuated Vaccines 43
8.1.2 Inactivated Vaccines 43
8.1.3 Recombinant Vaccines 44
8.1.4 Toxoid Vaccines 44
9 Global Veterinary/Animal Vaccines Market, by Region
9.1 Introduction 46
9.2 Americas 48
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.2.1 North America 51
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.2.1.1 US 53
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.2.1.2 Canada 55
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.2.2 South America 57
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3 Europe 60
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1 Western Europe 63
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1.1 France 65
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1.2 Germany 67
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1.3 UK 69
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1.4 Spain 71
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1.5 Italy 73
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.1.6 Rest of Western Europe 75
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.3.2 Eastern Europe 77
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4 Asia-Pacific 80
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4.1 Japan 83
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4.2 China 85
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4.3 India 87
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4.4 Australia 89
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4.5 Republic of Korea 91
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.4.6 Rest of Asia-Pacific 93
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.5 Middle East and Africa 95
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.5.1 Middle East 98
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
9.5.2 Africa 100
Veterinary/Animal Vaccines Market, by Type
Veterinary/Animal Vaccines Market, by Technology
10 Competitive Landscape
10.1 Introduction 103
11 Company Profiles
11.1 Boehringer Ingelheim International GmbH 106
11.1.1 Company Overview 106
11.1.2 Financial Overview 106
11.1.3 Products/Services Offered 107
11.1.4 Key Developments 107
11.1.5 SWOT Analysis 107
11.1.6 Key Strategies 107
11.2 Zoetis 108
11.2.1 Company Overview 108
11.2.2 Financial Overview 108
11.2.3 Products/Services Offered 109
11.2.4 Key Developments 109
11.2.5 SWOT Analysis 110
11.2.6 Key Strategies 110
11.3 Ceva 111
11.3.1 Company Overview 111
11.3.2 Financial Overview 111
11.3.3 Products/Services Offered 112
11.3.4 Key Developments 112
11.3.5 SWOT Analysis 113
11.3.6 Key Strategies 113
11.4 MSD & Co. Inc. 114
11.4.1 Company Overview 114
11.4.2 Financial Overview 114
11.4.3 Products/Services Offered 115
11.4.4 Key Developments 116
11.4.5 SWOT Analysis 116
11.4.6 Key Strategies 116
11.5 Elanco 117
11.5.1 Company Overview 117
11.5.2 Financial Overview 117
11.5.3 Products/Services Offered 118
11.5.4 Key Developments 118
11.5.5 SWOT Analysis 118
11.5.6 Key Strategies 119
11.6 Virbac 120
11.6.1 Company Overview 120
11.6.2 Financial Overview 120
11.6.3 Products/Services Offered 121
11.6.4 Key Developments 121
11.6.5 SWOT Analysis 121
11.6.6 Key Strategies 121
11.7 Phibro Animal Health Corporation. 122
11.7.1 Company Overview 122
11.7.2 Financial Overview 122
11.7.3 Products/Services Offered 123
11.7.4 Key Developments 123
11.7.5 SWOT Analysis 123
11.7.6 Key Strategies 123
11.8 Hipra 124
11.8.1 Company Overview 124
11.8.2 Financial Overview 124
11.8.3 Products/Services Offered 124
11.8.4 Key Developments 125
11.8.5 SWOT Analysis 125
11.8.6 Key Strategies 125
11.9 IDT Biologika GmbH 126
11.9.1 Company Overview 126
11.9.2 Financial Overview 126
11.9.3 Products/Services Offered 126
11.9.4 Key Developments 126
11.9.5 SWOT Analysis 127
11.9.6 Key Strategies 127
11.10 Biogenesis Bago SA 128
11.10.1 Company Overview 128
11.10.2 Financial Overview 128
11.10.3 Products/Services Offered 128
11.10.4 Key Developments 128
11.10.5 SWOT Analysis 129
11.10.6 Key Strategies 129
12 Appendix
12.1 Discussion Blue Print 131
13 List of Tables
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 PRIMARY INTERVIEWS 21
TABLE 3 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 36
TABLE 4 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 36
TABLE 5 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 37
TABLE 6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY REGION, 2020–2027 (USD MILLION) 37
TABLE 7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR PORCINE VACCINES, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 8 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY REGION, 2020–2027
(USD MILLION) 38
TABLE 9 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR POULTRY VACCINES, BY REGION, 2020–2027 (USD MILLION) 39
TABLE 10 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR AQUACULTURE VACCINES, BY REGION, 2020–2027 (USD MILLION) 39
TABLE 11 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 42
TABLE 12 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVE ATTENUATED VACCINES, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 13 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR INACTIVATED VACCINES, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 14 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR RECOMBINANT VACCINES, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 15 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR TOXOID VACCINES, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 16 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 47
TABLE 17 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 48
TABLE 18 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 49
TABLE 19 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 49
TABLE 20 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 50
TABLE 21 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 50
TABLE 22 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 51
TABLE 23 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 51
TABLE 24 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 52
TABLE 25 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 52
TABLE 26 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 53
TABLE 27 US: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 53
TABLE 28 US: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 54
TABLE 29 US: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 54
TABLE 30 US: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 55
TABLE 31 CANADA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 55
TABLE 32 CANADA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 56
TABLE 33 CANADA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 56
TABLE 34 CANADA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 57
TABLE 35 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 57
TABLE 36 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 58
TABLE 37 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 58
TABLE 38 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59
TABLE 39 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 60
TABLE 40 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 61
TABLE 41 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 61
TABLE 42 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 43 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 62
TABLE 44 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63
TABLE 45 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 46 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 64
TABLE 47 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 64
TABLE 48 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 65
TABLE 49 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 65
TABLE 50 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 51 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 52 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 67
TABLE 53 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 54 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 55 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 68
TABLE 56 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 69
TABLE 57 UK: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 58 UK: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 59 UK: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 60 UK: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71
TABLE 61 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 62 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 63 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 64 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 73
TABLE 65 ITALY: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 66 ITALY: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 67 ITALY: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 68 ITALY: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75
TABLE 69 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 70 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
(USD MILLION) 76
TABLE 71 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 72 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 77
TABLE 73 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 77
TABLE 74 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 75 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 78
TABLE 76 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 79
TABLE 77 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 78 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 79 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 80 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 82
TABLE 81 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 82
TABLE 82 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 83 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 84 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 85 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 84
TABLE 86 CHINA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 87 CHINA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 88 CHINA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 89 CHINA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86
TABLE 90 INDIA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 87
TABLE 91 INDIA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 87
TABLE 92 INDIA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 93 INDIA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88
TABLE 94 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 95 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 96 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 90
TABLE 97 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90
TABLE 98 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 99 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
(USD MILLION) 91
TABLE 100 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 92
TABLE 101 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92
TABLE 102 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 103 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
(USD MILLION) 93
TABLE 104 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 94
TABLE 105 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94
TABLE 106 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 95
TABLE 107 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 108 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
(USD MILLION) 96
TABLE 109 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 110 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 97
TABLE 111 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 112 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 113 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
(USD MILLION) 99
TABLE 114 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 99
TABLE 115 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 116 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 117 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 118 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101
14 List of Figures
FIGURE 1 RESEARCH PROCESS 21
FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 24
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VETERINARY/ANIMAL VACCINES MARKET 26
FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL VETERINARY/ANIMAL VACCINES MARKET 30
FIGURE 5 SUPPLY CHAIN: GLOBAL VETERINARY/ANIMAL VACCINES MARKET 32
FIGURE 6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020 (% SHARE) 35
FIGURE 7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020 & 2027 35
FIGURE 8 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY,2020 (% SHARE) 41
FIGURE 9 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020 & 2027 42
FIGURE 10 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020 (% SHARE) 46
FIGURE 11 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 46
FIGURE 12 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2020 (% SHARE) 48
FIGURE 13 EUROPE: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2020 (% SHARE) 60
FIGURE 14 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 80
FIGURE 15 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2020 (% SHARE) 95
FIGURE 16 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, MARKET SHARE ANALYSIS 2020 (%) 103